A patient who has had an MI is taking a beta-blocker. What is the main benefit of beta-blocker therapy for this patient?

Choice A rationale Beta-blockers reduce the workload on the heart by blocking the effects of catecholamines (epinephrine and norepinephrine) on beta-adrenergic receptors. This action leads to a decrease in heart rate, a reduction in the force of myocardial contraction (contractility), and a decrease in blood pressure. These effects collectively lower the heart's oxygen demand, which is crucial in preventing further damage after a myocardial infarction. Choice B rationale Beta-blockers do the opposite of this. They reduce heart rate and contractility by inhibiting the sympathetic nervous system's effect on the heart. This action is beneficial because it reduces the heart's workload and oxygen demand, helping to prevent further ischemic damage. Increasing heart rate and contractility would be detrimental to a post-MI patient as it would increase myocardial oxygen demand. Choice C rationale While beta-blockers do not directly cause coronary artery vasodilation, they improve overall coronary blood flow by reducing heart rate and increasing diastolic time. This allows more time for blood to flow through the coronary arteries to the myocardium. Calcium channel blockers or nitrates are the medications primarily used for direct vasodilation of the coronary arteries. Choice D rationale Beta-blockers do not prevent the formation of blood clots. This is the primary function of antiplatelet agents (like aspirin or clopidogrel) and anticoagulants (like heparin or warfarin). These medications work by inhibiting different parts of the coagulation cascade or platelet aggregation to prevent thrombosis in the coronary arteries.